RENALYSE

Renalyse is a healthtech company focused on developing a next-generation point-of-care diagnostic platform based on microfluidics and biosensor technology. Our mission is to enable rapid, accurate and accessible detection of critical health conditions directly at the point of care, supporting faster and better-informed clinical decision-making.

The company is developing a scalable platform designed to analyse small-volume blood samples and deliver near real-time diagnostic results. By decentralising key laboratory functions, Renalyse aims to reduce diagnostic delays and improve patient management in time-sensitive settings such as emergency care, primary care and chronic disease monitoring.

Our technology integrates microfluidic sample handling, advanced sensing technologies and digital health capabilities, with future potential for AI-driven interpretation and clinical decision support. This combination is intended to improve diagnostic accuracy, usability and integration within existing healthcare workflows.

Renalyse is currently advancing its solution towards clinical validation and industrialisation, seeking to build strong European partnerships to accelerate development, ensure regulatory compliance and enable successful market adoption.